Pharmafile Logo
Pharmafocus logo
Advanced Search

MSI

Showing 13 posts of 28 posts found.

Using the corporate brand in pharma

March 6, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Marks, MSI, brand, branding, brands

In many markets the corporate brand can add significant value and values to the portfolio of product brands and franchises. …

Feature
Elephant sign picture

Optimising your brand – one bite at a time

December 15, 2011
Business Services, Medical Communications, Sales and Marketing Alex Blyth, MSI, brand, marketing

Brand managers invest a huge amount of time every year preparing brand plans – but often without really knowing what …

Feature

Red Kite to merge with MSI

June 8, 2011
Sales and Marketing Cello, MSI, Red Kite, pharmaceutical marketing

Strategic marketing group Cello has expanded its healthcare portfolio with the acquisition of consultancy firm Red Kite. The move has …

News

Four steps to turn around a flagging pharma brand

February 21, 2011
Sales and Marketing MSI, branding, brands, marketing

The glamorous end of pharma marketing is undoubtedly around the launch of a new product. Everyone is excited and optimistic, …

Feature

A mature approach to relationships with pharma’s customers

December 6, 2010
Sales and Marketing MSI, Paul Stuart Kregor, franchise management, pharma marketing

Commercial managers who are responsible for a number of brands face a constant challenge in choosing where across the franchise …

Feature

A new generation of analogues for valuing strategy

November 22, 2010
Sales and Marketing Alex Blyth, MSI, forecasting, marketing, marketing strategy

Anyone who is involved in the planning of pharma marketing campaigns will know that the Holy Grail is trying to …

Feature

MSD’s Dan Heapy joins MSI

September 16, 2010
Sales and Marketing MSI, appointment, sales and marketing

The MSI Consultancy has appointed Dan Heapy as a consultant. He joins MSI from MSD, where over five years he …

Appointment

MSI promotes Michael Craig

July 26, 2010
Sales and Marketing MSI, appointment, sales and marketing

The MSI Consultancy has promoted Michael Craig to the role of senior consultant. In his new role he will be …

Appointment

Soft skills for the commercial manager

February 11, 2010
Business Services, Sales and Marketing MSI, leadership, sales force effectiveness, sales representatives, skills

The healthcare industry is changing. In pharma, the new rising commercial leaders, business unit heads, marketing managers, have both business …

Feature

MSI launches Brand Services division

January 18, 2010
Sales and Marketing MSI

The MSI Consultancy has launched a new division to help the pharma industry maximise the impact of its brands. The …

News

Train to retain: holding onto your best people

January 13, 2010
Business Services, Sales and Marketing MSI, careers, training

It’s a widely-held myth that retaining staff is easy in a recession. As jobs are cut the attraction of staying …

Feature
Theodora-Anastasi-of-The-MSI-Consultancy

Pfizer UK’s Theodora Anastasi joins The MSI Consultancy

December 14, 2009
Sales and Marketing MSI, appointment, sales and marketing

Pharmaceutical consultancy firm The MSI Consultancy has appointed Theodora Anastasi as a consultant.

Appointment

Marketers: get more bang for your buck

October 1, 2009
Medical Communications MSI, marketing

Pharma marketing is under increasing pressure to demonstrate how it adds value, especially when it comes to justifying expenditure. Brand …

Feature
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026